ARCHIVES

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years

July 30, 1982

Nancy Brinker Resigns As CEO of Komen

August 10, 2012

President’s FY 1991 Budget Provides NCI 3.9% Increase, But Grant Budgets To Be Cut 20%

February 2, 1990

NCI brings in grantees to explain their work, promise of nanotech, to advisory board.

July 16, 2004

NCI Branch Chiefs, ACCI Join Support For DeVita

June 25, 1981